Capstone Investment Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-6,593
| Closed | -$189K | – | 533 |
|
|
2019
Q3 | $189K | Buy |
+6,593
| New | +$189K | ﹤0.01% | 300 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 532 |
|
|
2017
Q1 | – | Sell |
-38,782
| Closed | -$646K | – | 838 |
|
|
2016
Q4 | $646K | Buy |
+38,782
| New | +$646K | 0.02% | 397 |
|
|
2016
Q3 | – | Sell |
-19,600
| Closed | -$599K | – | 736 |
|
|
2016
Q2 | $599K | Buy |
19,600
+13,000
| +197% | +$397K | 0.01% | 356 |
|
|
2016
Q1 | $247K | Sell |
6,600
-3,510
| -35% | -$131K | 0.01% | 496 |
|
|
2015
Q4 | $436K | Buy |
+10,110
| New | +$436K | 0.01% | 267 |
|